In cases of sepsis, C5aRa treatment hindered the chemotactic responses of neutrophils to C5a, thereby preventing C5a/C5aR-induced impairment of innate immunity, resulting in enhanced survival during a 9-day investigation. Here, C5AR1 is linked to Sepsis.